Asthma

Download this document in word/pdf format Email this link to a friend Notepad - write or copy&paste notes, then email them to yourself Print this page Contact us



Bronchial Asthma: introduction


- No universally accepted definition.
- An inflammatory condition causing reversible airways obstruction.
- Prevalence (UK): 10 – 15 %

[Return to top]


Classification


Extrinsic:
- develops in childhood
- associated with atopy
- often remits in adolescence

Intrinsic:*
- adult-onset
- not allergic
- progressive / poor response to treatment

Occupational
- work-place allergens

* consider other differential diagnosis if severe / adult-onset asthma:
- ABPA
- bronchiectasis
- Churg-Strauss syndrome (a systemic vasculitis)

[Return to top]


Clinical features


'Tetrad' of symptoms:
- dyspnoea
- chest tightness
- wheeze
- cough

Reversible diurnal variation:
- keep a PEFR (peak expiratory flow rate) diary = morning dipping
- improvement with a Beta-2-agonist (e.g. salbutamol)

Triggers:

1. Environmental
- exercise
- cold air
- emotional (anxiety)
- viral URTI (upper resp tract infection)

2. Allergens
- dust mite
- cat / dog dander
- pollens
- occupational (e.g. photocopiers)

3. Drugs
- aspirin
- beta-blockers

[Return to top]


Management of Chronic Asthma


Assess severity
"In the last week / month..."
- have you had difficulty sleeping because of asthma (inc. cough)
- have you had your usual asthma Sx during the day
- has your asthma interfered with your usual activities

Conservative Mx
1. Lifestyle - stop smoking
- lose weight

2. Allergens
- pets - avoid exposure
- rigorous measures to remove house dust mites

British Thoracic Society guidelines: stepwise management (adults)

STEP 1
-(inhaled) short-acting beta-2 agonist (PRN, as required)

STEP 2
- (inhaled) short-acting beta-2 agonist (PRN, as required)
- (inhaled) steroid 200–800 mg OD (usually taken as an am+pm dose)

STEP 3
- add LABA (long acting beta-agonist)

- if GOOD response: continue LABA
- if MODERATE response: continue LABA & increase steroids to 800 mg OD
- if POOR response: stop LABA & trial of other drugs, such as leukotrine antagonists (e.g. Montelukast) or theophylline (e.g. aminophylline)

STEP 4
- trial of (inhaled) steroid up to 2000 mg OD
- trial of 4th drug (e.g. leukotrine antagonists (e.g. Montelukast), theophylline (e.g. aminophylline), oral beta-2 agonist)

STEP 5
- (inhaled) steroid 2000 mg OD
- (PO, oral) steroid at lowest dose providing adequate control
- other drugs as required to minimise steroid use
- specialist referral

NB: step down after 3 – 6 months of stability

[Return to top]


Acute asthma: general management


Resuscitate
A
B: 100% O2
C
D: assess conscious level

Acute asthma: initial assessment
GCS

Vital signs
- RR
- HR
- SaO2

Ability to speak
- sentences / words / grunts
- ± quantify (count to 10)

Respiratory examination
- colour
- accessory muscles
- auscultation
- PEFR

History
- timecourse
- best ever PEFR (preferable to nomogram)
- treatment used

[Return to top]


Acute asthma: investigation


ABG*
- if SaO2 <92%
- PaCO2 >5kPa = severe asthma (but response to treatment is most important)

CXR
- exclude pneumothorax
- exclude pneumonia

Bloods: Urea & Electrolytes
- beta-agonists can cause hypokalaemia (low K+)

* interpret ABGs in the context of the resp. rate, e.g. if PaCO2 is normal @ RR 30, then patient is retaining CO2, as should really have low PaCO2 if hyperventilating

[Return to top]


British Thoracic Society guidelines: classification of severity


Mild
- PEFR > 75%

Moderate
- PEFR < 75%

Severe asthma
- PEFR < 50%
- resp. rate > 24/min
- HR > 110/min
- cannot complete sentence in one breath
- (> 10 mmHg pulsus paradoxus)

Life-threatening asthma
- PEFR < 33%
- decreased GCS, exhaustion, poor respiratory effort
- increased HR, decreased BP, arrhythmia
- resp. rate < 8
- SaO2 < 92%
- cyanosis
- silent chest
- (> 20 mmHg pulsus paradoxus)

[Return to top]


Acute asthma: treatment


Mild asthma
- bronchodilator, e.g. salbutamol (inhaled)

Moderate – Severe asthma
- salbutamol 5 mg (O2 driven nebuliser) or terbutaline 10 mg
- prednisolone 40 mg (PO)
- hydrocortisone (IV steroid) usually used when patient is unconscious / unable to swallow

Life-threatening asthma
- call ITU
- nebulisers: salbutamol 5 mg (O2 driven neb, max rate = continuous) or ipratropium 500 mg (O2 driven neb, max rate = 3–4 hourly)
- IV bronchodilators: Magnesium Sulphate, aminophylline (poor evidence, side effects), salbutamol 250 mg
- these IV drugs all require senior supervision
- final consideration: aminophylline infusion

[Return to top]


Acute asthma: monitoring progress


Re-assess
- every 15 – 30 mins

Assess
- vital signs
- O2
- PEFR

Repeat ABG if:
- SaO2 < 92%
- if PaCO2 > 5 kPa

ITU if:
- decreased SaO2
- ­PaCO2
- exhaustion

[Return to top]


Acute asthma: stepping down treatment


In hospital:
- consider extended observation
- salbutamol (nebulised) until PEFR > 75%

Before discharge:
- check inhaler technique (respiratory nurse specialist)
- return if getting worse despite treatment
- return if cannot talk in sentences

After discharge:
- prednisolone 40 mg OD for 5 days

Follow-up:
- GP @ 2 days post-discharge
- chest (respiratory) clinic / respiratory nurse specialist

[Return to top]




Click Here to shop at eBay.co.uk

Elite medical courses
Streamline.Net - 100,000 sites hosted, join the revolution! - The home of good value web hosting
HONcode accreditation seal.
For health trustworthy information

>criteria

>verify